Grifols, S.A. has grown revenue 14% a year over three years and 7.2% a year over five, with earnings per share compounding at −6.3%. Revenue growth, 3-year annual rate: +14% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +7.2%, growth has picked up over the last three years. Earnings per share, 3-year rate: −6.3%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 10, FY2015 to FY2024, as filed.

GRFSGrifols, S.A.

HealthcareUSD

$7.89

$7.0052 weeks$10.74

Is it growing?

Is GRFS growing?

Grifols, S.A. has grown revenue 14% a year over three years and 7.2% a year over five, with earnings per share compounding at −6.3%.

+14%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +7.2%
Revenue growth, 5-year rate · +14% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: −6.3%
Earnings per share, 3-year rate · revenue +14% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 10
Years of annual history on file · FY2015 to FY2024, as filed